Skip to main content

Table 2 Patient characteristics of 109 SLND

From: Endometrial cancer—how many patients could benefit from sentinel lymph node dissection?

Age, years (range)

Median

63.5

(28–89)

Grading, uterus-specimen

G1

57

52%

G2

30

28%

G3

22

20%

Histopathological type

 Type I

 

99

91%

 Type II

 

10

9%

Serous

 

6

Clear cell

 

1

Carcinosarcoma

 

3

Uterine risk factors

Low risk

53

49%

Intermediate risk

25

23%

High-intermediate risk

13

12%

High risk

18

17%

Nodal involvement

Low risk

0

0%

Intermediate risk

3

12%

High-intermediate risk

7

54%

High risk

11

61%

Final FIGO stage

IA

60

55%

IB

23

21%

II

5

5%

IIIC1

10

9%

IIIC2

5

5%

IIIA

1

1%

IVB

5

5%